MétaCan
Menu
Back to cohort
Record W4415547445 · doi:10.1016/j.cjco.2025.10.007

Outcomes, Safety and Tolerability of Sacubitril-Valsartan over 3 years of Follow-up in Canadian Practice: Insights from the PARTHENON Registry

2025· article· en· W4415547445 on OpenAlexafffundabout
Michael McDonald, Melanie Kok, Anique Ducharme, Justin A. Ezekowitz, Jonathan G. Howlett, Carlos Rojas‐Fernandez, Jacob A. Udell

Bibliographic record

VenueCJC Open · 2025
Typearticle
Languageen
FieldMedicine
TopicHeart Failure Treatment and Management
Canadian institutionsWomen's College HospitalUniversity of CalgaryLibin Cardiovascular Institute of AlbertaWomen and Children’s Health Research InstituteUniversité de MontréalMontreal Heart InstituteNovartis (Canada)
FundersNovartis Pharmaceuticals CanadaNovo NordiskCytokineticsSanofiAstraZenecaAlnylam PharmaceuticalsAmerican RegentServierPfizerAmgen
KeywordsTolerabilityContext (archaeology)Clinical trialMEDLINE

Abstract

fetched live from OpenAlex

Background: Experience with sacubitril-valsartan in real-world patients with heart failure and reduced ejection fraction (HFrEF) is congruent with findings from clinical trials. Detailed assessment of safety and clinical outcomes in the Canadian context is less well explored. Methods: The PAtient RegisTry assessing effectiveness and safety of HEart failure treatment with LCZ696 acrOss CaNada (PARTHENON) was a prospective, observational, multicentre study. Patients with HFrEF who were prescribed sacubitril-valsartan were recruited from 32 sites across Canada and followed for at least 3 years. The primary outcome was the association between baseline natriuretic peptide levels and the combined endpoint of all-cause mortality or all-cause hospitalization. Secondary outcomes included incidence of hypotension, hyperkalemia, and renal impairment. Additionally, observed all-cause mortality was compared with risk-model predicted mortality. Results: A total of 996 patients were enrolled in the registry; 19.1% discontinued the study early, and 10.8% died. No statistically significant association occurred between baseline natriuretic peptide levels and all-cause mortality or all-cause hospitalization (adjusted hazard ratio 1.04; 95% confidence interval: 0.91-1.20). Clinically relevant hypotension, hyperkalemia, and an increased creatinine level were observed in 24%, 4%, and 24%, respectively. The mean absolute change in left ventricular ejection fraction over 18 months was +8.2% +/- 10.8%. The observed 3-year mortality rate was lower than the 3-year mortality rate predicted by the Meta-Analysis Global Group in Chronic (MAGGIC) risk score (10.8%, vs 29% +/- 13.7%); observed survival was higher than the Seattle Heart Failure Model predicted survival (89.2%, vs 53.4% +/- 26.4%). Conclusions: The PARTHENON registry confirms the safety and tolerability of sacubitril-valsartan in patients with HFrEF in a real-world setting. The registry also demonstrated improvement in left ventricular ejection fraction, and a lower mortality rate, compared to the predicted mortality rate in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.301
Threshold uncertainty score0.592

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.319
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueCJC OpenSame topicHeart Failure Treatment and ManagementFrench-language works237,207